首页 › 基金 › EcoR1 Capital, LLC › NRIX
EcoR1 Capital, LLC 对 NRIX 的持仓历史
NURIX THERAPEUTICS INC · 医疗保健
EcoR1 Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 NRIX(NURIX THERAPEUTICS INC)375,000 股,市值约 US$8.9M,约占其申报组合的 0.42%,在其申报持仓中市值排名第 24 位。 EcoR1 Capital, LLC 最近 2 个申报季度中有 2 个季度披露了 NRIX 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
EcoR1 Capital, LLC 对 NRIX 的持仓演变
EcoR1 Capital, LLC 于 Q2 2026 首次披露 NRIX 持仓:270,000 股(约 US$6.6M)。 该持仓在 Q3 2026 达到峰值 375,000 股,市值约 US$8.9M。 在 2 次申报中,EcoR1 Capital, LLC 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 375,000 股、市值约 US$8.9M,环比增持 105,000 股。。 持仓曾出现大幅变动:Q3 2026 增持约 39% (随后一个季度股价下跌 35%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 270.00K | $6.55M | 新进 |
| Q3 2026 | 375.00K | $8.89M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NRIX 与 13F 数据
NRIX(NURIX THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 NRIX,申报仓位最大的包括:Vestal Point Capital, LP (US$195.3M), Rubric Capital Management LP (US$175.3M), Deep Track Capital, LP (US$142.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NRIX 的基金
- Vestal Point Capital, LP 8.05M 股 · $195.29M · Q2 2026
- Rubric Capital Management LP 7.23M 股 · $175.35M · Q2 2026
- Deep Track Capital, LP 6.00M 股 · $142.26M · Q3 2026
- BAKER BROS. ADVISORS LP 4.66M 股 · $113.02M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.32M 股 · $104.81M · Q2 2026
- Redmile Group, LLC 4.07M 股 · $98.83M · Q2 2026
- GENERAL ATLANTIC, L.P. 3.03M 股 · $71.89M · Q3 2026
- Trails Edge Capital Partners, LP 1.57M 股 · $37.30M · Q3 2026
- Soleus Capital Management, L.P. 1.47M 股 · $35.54M · Q2 2026
- BRAIDWELL LP 1.29M 股 · $31.22M · Q2 2026
- Kynam Capital Management, LP 1.19M 股 · $28.33M · Q3 2026
- Affinity Asset Advisors, LLC 967.62K 股 · $22.94M · Q3 2026
更多关于 EcoR1 Capital, LLC
常见问题
How long has EcoR1 Capital, LLC held NRIX?
EcoR1 Capital, LLC has disclosed NRIX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is EcoR1 Capital, LLC's current position in NRIX?
As of Q3 2026, EcoR1 Capital, LLC holds 375.00K shares of NRIX (NURIX THERAPEUTICS INC), valued at $8.89M, representing 0.42% of its reported portfolio and ranking #24.
Has EcoR1 Capital, LLC been buying or selling NRIX?
In the latest 13F filing (Q3 2026), EcoR1 Capital, LLC increased its position in NRIX. The position peaked in Q3 2026 at 375.00K shares.
Which other funds hold NRIX?
Other major institutional holders of NRIX include Vestal Point Capital, LP, Rubric Capital Management LP, Deep Track Capital, LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.